一级婬片试看120分钟,安徽少妇BBBB搡BBBB,波多野结衣一级片

香蕉91成人一区二区三区飘花,91精品人妻一区二区三区蜜桃,四川少妇BBw搡BBBB槡BBBB,国产成人91一区二区三区APP

<tr id="cc0cc"></tr>

<nav id="cc0cc"></nav><small id="cc0cc"></small>

<sup id="cc0cc"></sup>

CN

CN EN

Latest News

Latest News Media Downloads Video Center

Kexing Biopharm's clinical trial application accepted for human interferon α1b inhalation solution
2022-08-19

2022-08-19

On the evening of August 18, 2022, Kexing Biopharm...
Kexing Biopharm's clinical trial application accepted for another dosage form of human interferon α2b
2022-08-15

2022-08-15

On the evening of August 14, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had recently received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Human Interferon α2b Spray" was accepted.
Kexing Biopharm's clinical trial application accepted for "Pegylated Human Granulocyte Colony-stimulating Factor Injection"
2022-08-02

2022-08-02

On the evening of August 1, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had just received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Pegylated Human Granulocyte Colony-stimulating Factor Injection" was accepted.
Kexing Biopharm's conference for reviewing operation and management in first half of 2022and planning key tasks for the second half-year held successfully
2022-08-01

2022-08-01

In the face of the complicated political and economic environment in China and overseas as well as the tough situation in the pharmaceutical industry, Kexing Biopharm proposed the working policy themed as "intensely licensing in new products, firmly promoting R&D and innovation, and proactively creating business in new industries" at the beginning of the year, and continuously followed and implemented the policy in the first half-year.
Phase I clinical trial kick-off meeting of Kexing Biopharm's COVID-19 oral drug SHEN26 Capsule held successfully
2022-07-22

2022-07-22

On July 20, 2022, the phase I clinical trial kick-off meeting of SHEN26 Capsule, a small-molecule oral drug against COVID-19 jointly developed by Shenzhen Kexing Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kexing Biopharm (688136.SH), and Shenzhen Antiv Pharma Co., Ltd., was successfully held in the Second Affiliated Hospital of Anhui Medical University, indicating the official start of the clinical study for the project.

1 2 3 4 5

Support Hotline

0755-26546500
Online Consultation
QR Code

Scan Code Consultation

国产成人精品秘久久久 | 东方av影库在线观看 | 99成人兔费视频在线播放 | 国产精品秘入勒来来来 | 丰满少妇一级A片免费 | 成人A片产无码免费视频奶头麻豆 | 欧美性猛交XXXX乱大交3未删减版 | 前田香织无码一区二区 | 4444www大胆无码视频α级 | 波多野结衣乳巨码在线直播 | 成人午夜婬片A片免费直播四虎8848成人永久视频 | 美女性爱按摩视频 | 成人A片网站发布地址 | 成人做爰黄片视频真人 | 国产一级a毛一级a做免费高清视频 | 国产精品一区二区视频 | 五月婷婷综合激情 | 上海熟妇搡BBBB搡BBBB | 91精品国产综合久久久果冻传媒 | 高清国产一级婬片A片大黄九色 | 免费在线观看WWW视频 | 狠狠色婷婷7777久夜色撩人Ⅰ | 亚洲精品毛A片久久久爽 | 中文字幕日韩欧美一区二区三区 | 亚洲精品无码AAAAA爱的色放 | 无码人妻一区二区蜜桃 | 国产亲妺妺乱视频免费看 | 四川少妇搡bbbb搡bbbb | 欧美性爱xxxx黑人xyx性爽 | 少妇搡BBBB搡BBB搡打电话 | 无码精品一区二区三区四区爱奇艺 | 偷拍裸体美女福利视频 | 天天干天天干天天插天天爽 | 人妻中文字幕在线 | 中文字幕在线免费看 | 亚洲秘无码一区小野夕子天津熟女露脸91熟女人妻 | 熟女岳胥乱一区二区三区免费看 | 国产日韩欧美在线 | 欧美一级片免费观看 | 午夜影院在线观看视频 | 农村婬乱男女A片爽视频麻豆软件 |

<tfoot id="ccccc"><dd id="ccccc"></dd></tfoot>

<nav id="ccccc"></nav>

<tr id="ccccc"></tr><tr id="ccccc"></tr>

<noscript id="ccccc"><dd id="ccccc"></dd></noscript>